Skip to main content

Advertisement

Table 1 Characteristics of the study population

From: Role of TRAP1 and estrogen receptor alpha in patients with ovarian cancer -A study of the OVCAD consortium

Study population divided into TRAP1-low and TRAP1-high
N = 208 TRAP1-low TRAP1-high   
Characteristics n = 93 (%) n = 115 (%) p Adjusted p
Age
≤ 55 (n = 98) 49 (23.6) 49 (23.6)   
> 55 (n = 110) 44 (21.2) 66 (31.7) 0.148  
Histology
Serous (n = 183) 76 (36.5) 107 (51.4)   
Non-serous1 (n = 25) 17 (8.2) 8 (3.8) 0.013 0.078
FIGO
II (n = 9) 5 (2.4) 4 (1.9)   
III (n = 164) 70 (33.6) 94 (45.2) 0.5262  
IV (n = 35) 18 (8.7) 17 (8.2)  
Grade (1missing)
Grade 1&2 (n = 55) 19 (9.2) 36 (17.4)   
Grade 3 (n = 152) 73 (35.3) 79 (38.2) 0.087  
Residual tumor
no (n = 146) 64 (30.8) 82 (39.4)   
> 0 cm (n = 62) 29 (13.9) 33 (15.9) 0.697  
Peritoneal Carcinomatosis
no (n = 64) 28 (13.5) 36 (17.3)   
yes (n = 144) 65 (31.5) 79 (38.0) 0.852  
  1. 1Endometrioid (n = 9), mixed epithelial (n = 9), mucinous (n = 1), undifferentiated (n = 4), and clear-cell carcinoma (n = 2).2Fisher’s Exact test.